Pneumococcal resistance in perspective: How well are we combating it?

Pediatric Infectious Disease Journal

Volumn 23, Issue 2, 2004, Pages

  Amsden, Guy W ^a  

^a BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

Antibiotic resistance; Conjugate vaccine; Pneumococcus

Indexed keywords

ANTIBIOTIC AGENT; MACROLIDE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; BACTERIAL TRANSMISSION; BRONCHITIS; COMMON COLD; CONFERENCE PAPER; DAY CARE; HEALTH EDUCATION; HUMAN; IMMUNIZATION; OTITIS MEDIA; PRESCRIPTION; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

EID: 1242336816     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000112526.55182.e0     Document Type: Conference Paper

References (16)

1. Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 1998;279:875-7.
2. Emmer CL, Besser RE. Combating antimicrobial resistance: intervention programs to promote appropriate antibiotic use. Infect Med 2002;19:160-73.
3. Mangione-Smith R, McGlynn EA, Elliott MN, Krogstad P, Brook RH. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics 1999;103:711-18.
4. Finkelstein JA, Davis RL, Dowell SF, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics 2001;108:1-7.
5. Perz JF, Craig AS, Coffey CS, et al. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA 2002;287:3103-9.
6. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002; 287:3096-102.
7. Waterer GW, Buckingham SC, Kessler LA, Quasney MW, Wunderink RG. Decreasing beta-lactam resistance in pneumococci from the Memphis region: analysis of 2152 isolates from 1996 to 2001. Chest 2003;124:519-25.
8. Karlowsky JA, Thornsberry C, Jones ME, Evangelista AT, Critchley IA, Sahm DF. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). Clin Infect Dis 2003;36:963-70.
9. Hoban DJ, Nichol K, Palatnick L, Gin A, Low D, Zhanel GG. Decreasing incidence of penicillin non-susceptible Streptococcus pneumoniae (SPN) in Canada: Results on an ongoing national surveillance study-1997-2001 [Abstract C2-2102]. In: 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, December 16 to 19, 2001. Washington, DC: American Society for Microbiology, 2001.
10. Cercenado E, Gomez JA, Bouza E. Is incidence of penicillin-resistant Streptococcus pneumoniae decreasing in Spain? [Abstract C2-2101]. In: 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, December 16 to 19, 2001. Washington, DC: American Society for Microbiology, 2001.
11. Schito GC, Debbia EA, Marchese A. The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. J Antimicrob Chemother 2000;46(Suppl T1):3-9.
12. Whitney CG. The potential of pneumococcal conjugate vaccines for children. Pediatr Infect Dis J 2002;21:961-70.
13. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-9.
14. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumocccal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348: 1737-46.
15. Dagan R, Givon-Lavi N, Zamir O, Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J 2003;22:532-9.
16. Givon-Lavi N, Fraser D, Dagan R. Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings. Pediatr Infect Dis J 2003;22:524-31.